Earnings estimate revisions
Search documents
Why Coherent (COHR) Might be Well Poised for a Surge
ZACKS· 2025-11-12 18:21
Core Insights - Coherent (COHR) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise earnings estimates [1][2] - The upward trend in earnings estimate revisions indicates growing analyst optimism, which is expected to positively impact the stock price [2][3] Current-Quarter Estimate Revisions - For the current quarter, Coherent is projected to earn $1.20 per share, reflecting a 26.3% increase from the previous year [6] - In the last 30 days, six estimates have been revised upward with no negative revisions, leading to a 10.28% increase in the Zacks Consensus Estimate [6] Current-Year Estimate Revisions - The full-year earnings estimate stands at $5.02 per share, representing a 42.2% increase from the prior year [7] - Over the past month, seven estimates have been raised with no negative revisions, indicating a positive trend for the current year [7] Zacks Rank and Performance - Coherent currently holds a Zacks Rank 2 (Buy), supported by favorable estimate revisions [8] - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [8] Stock Performance - Coherent's stock has risen by 44.5% over the past four weeks due to strong estimate revisions, suggesting potential for further upside [9]
Royal Gold (RGLD) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2025-11-12 18:01
Core Viewpoint - Royal Gold (RGLD) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook driven by an upward trend in earnings estimates [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which significantly influence stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Company Performance and Outlook - The upgrade for Royal Gold reflects an improvement in its underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - For the fiscal year ending December 2025, Royal Gold is expected to earn $7.96 per share, with a 6.3% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks based on earnings estimate revisions, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Royal Gold's upgrade places it in the top 5% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10].
XOMA Royalty (XOMA) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2025-11-12 14:46
Core Insights - XOMA Royalty reported a quarterly loss of $0.35 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.02, representing an earnings surprise of -1,650% [1] - The company generated revenues of $9.35 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 25.7%, but showing an increase from $7.2 million in the same quarter last year [2] - XOMA Royalty shares have increased by approximately 31.2% year-to-date, outperforming the S&P 500's gain of 16.4% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.15 on revenues of $13.46 million, and for the current fiscal year, it is $0.62 on revenues of $55.05 million [7] - The estimate revisions trend for XOMA Royalty was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Medical - Biomedical and Genetics industry, to which XOMA Royalty belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - VistaGen Therapeutics, another company in the same industry, is expected to report a quarterly loss of $0.51 per share, reflecting a year-over-year change of -21.4% [9]
European Wax Center, Inc. (EWCZ) Beats Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-12 13:15
Core Insights - European Wax Center, Inc. (EWCZ) reported quarterly earnings of $0.25 per share, exceeding the Zacks Consensus Estimate of $0.14 per share, and showing an increase from $0.12 per share a year ago, resulting in an earnings surprise of +78.57% [1] - The company achieved revenues of $54.19 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.65%, although this represents a decline from $55.43 million in the same quarter last year [2] - The stock has underperformed, losing approximately 45.3% year-to-date compared to the S&P 500's gain of 16.4% [3] Earnings Performance - Over the last four quarters, European Wax Center has consistently surpassed consensus EPS estimates, achieving this four times [2] - The company is currently rated Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.10 on revenues of $46.9 million, and for the current fiscal year, it is $0.69 on revenues of $207.03 million [7] - The earnings outlook will be influenced by management's commentary during the earnings call, which is crucial for assessing future stock movements [4][5] Industry Context - The Cosmetics industry, to which European Wax Center belongs, is currently ranked in the bottom 12% of over 250 Zacks industries, which may impact stock performance [8]
Evolution Petroleum (EPM) Reports Break-Even Earnings for Q1
ZACKS· 2025-11-11 23:26
Core Insights - Evolution Petroleum (EPM) reported break-even quarterly earnings per share, matching the Zacks Consensus Estimate of $0.02, with adjusted figures showing no change from the previous year [1] - The company posted revenues of $21.29 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 1.9% and down from $21.9 million a year ago [2] - The stock has underperformed, losing approximately 14.9% since the beginning of the year, while the S&P 500 has gained 16.2% [3] Earnings Performance - Over the last four quarters, Evolution Petroleum has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $21.45 million, and for the current fiscal year, it is $0.01 on revenues of $84.95 million [7] Market Outlook - The company's earnings outlook is critical for assessing future stock performance, with recent estimate revisions trending unfavorably, resulting in a Zacks Rank 4 (Sell) [6] - The Zacks Industry Rank for Oil and Gas - Exploration and Production - United States is in the bottom 26% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]
Enhabit (EHAB) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-11-11 18:01
Core Viewpoint - Enhabit (EHAB) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is influenced by changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for Enhabit reflects an improvement in the company's underlying business, suggesting that investors may push the stock price higher due to this positive trend [5]. - For the fiscal year ending December 2025, Enhabit is expected to earn $0.50 per share, with a 9.3% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong track record of performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - Enhabit’s upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)
ZACKS· 2025-11-11 15:35
Core Viewpoint - Codexis (CDXS) has experienced a significant downtrend, with a 30% decline over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key technical indicator used to determine if a stock is oversold, with readings below 30 indicating oversold conditions [2]. - CDXS has an RSI reading of 25.05, suggesting that the heavy selling pressure may be exhausting, indicating a possible bounce back towards equilibrium [5]. Group 2: Fundamental Analysis - Analysts have shown strong consensus in raising earnings estimates for CDXS, with a 0.5% increase in the consensus EPS estimate over the last 30 days, which typically correlates with price appreciation [7]. - CDXS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a near-term turnaround [8].
Palantir Technologies Inc. (PLTR) Just Overtook the 50-Day Moving Average
ZACKS· 2025-11-11 15:31
Core Viewpoint - Palantir Technologies Inc. (PLTR) has reached a significant support level and shows potential for investors from a technical perspective, indicating a short-term bullish trend after breaking through the 50-day moving average [1]. Technical Analysis - The 50-day simple moving average is a key indicator for traders and analysts to determine support or resistance levels, with PLTR recently breaking this level, suggesting a bullish trend [2]. - Over the past four weeks, PLTR has gained 9.3%, and it currently holds a Zacks Rank 2 (Buy), indicating further potential for stock price increases [2]. Earnings Estimates - There have been 9 upward revisions in PLTR's earnings estimates for the current fiscal year, with no downward revisions, reinforcing the bullish sentiment among investors [3]. - The consensus estimate for PLTR has also increased, further supporting the positive outlook for the stock [3].
Axcelis Technologies (ACLS) Recently Broke Out Above the 50-Day Moving Average
ZACKS· 2025-11-11 15:31
Core Viewpoint - Axcelis Technologies (ACLS) is showing potential for a bullish trend following a recent technical breakout and positive earnings estimate revisions [1][2][3] Technical Analysis - ACLS has recently surpassed the 50-day moving average, indicating a key level of support and suggesting a short-term bullish trend [1] - The 50-day simple moving average is a significant indicator for traders and analysts to assess support or resistance levels [1] Performance Metrics - ACLS has experienced a 7.4% increase over the last four weeks, indicating positive momentum [2] - The stock currently holds a Zacks Rank of 3 (Hold), reflecting a neutral outlook [2] Earnings Estimates - There have been no downward revisions in earnings estimates for ACLS in the past two months, while four estimates have been revised upward [2] - The consensus earnings estimate for ACLS has also seen an increase, reinforcing the bullish sentiment [2][3] Investment Outlook - Given the positive technical indicators and earnings estimate revisions, ACLS may present a compelling investment opportunity for potential gains in the near future [3]
Insights Into Canadian Solar (CSIQ) Q3: Wall Street Projections for Key Metrics
ZACKS· 2025-11-11 15:16
Core Insights - Canadian Solar (CSIQ) is expected to report a quarterly loss of -$1.08 per share, a decline of 248.4% year-over-year, with revenues forecasted at $1.37 billion, down 9.1% from the previous year [1] Earnings Estimates - The consensus EPS estimate for the quarter has been revised downward by 16.1% over the past 30 days, indicating a reassessment by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3] Revenue Projections - Analysts predict revenues for CSI Solar's solar modules to reach $841.65 million, reflecting a year-over-year decrease of 30.9% [5] - Revenues from CSI Solar's solar system kits are expected to be $126.97 million, indicating a year-over-year increase of 19.3% [5] - Revenues from CSI Solar's battery energy storage solutions are projected at $333.66 million, showing a significant year-over-year increase of 249.8% [6] - Revenues from CSI Solar's EPC and other services are anticipated to be $50.84 million, reflecting a year-over-year increase of 16.6% [6] - Total revenues for CSI Solar are expected to be $1.41 billion, indicating a year-over-year decline of 3.3% [6] - Revenues for Recurrent Energy are projected to reach $77.57 million, representing a year-over-year increase of 72.2% [7] Stock Performance - Canadian Solar shares have increased by 128.3% over the past month, significantly outperforming the Zacks S&P 500 composite, which rose by 4.4% [7] - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [7]